Additionally, Moody’s has assigned an “A3” rating to $127 million of series 2014A fixed rate bonds to be issued through the New Jersey Health Care Facilities Financing Authority on behalf of Barnabas Health.
The rating upgrade and assignment were supported by a number of factors, including Barnabas’ continued strong financial performance. The system recorded a 5.5 percent operating margin and a 10.7 percent operating cash flow margin through the nine months ending in September.
The rating upgrade was also supported by the elimination of the frozen Jersey City (N.J.) Medical Center pension plan and the completion of a seven-year repayment plan pursuant to a settlement with the Department of Justice, which were two major demands on Barnabas’ liquidity.
Barnabas faces some challenges, which were considered for the rating upgrade, such as the integration of Jersey City Medical Center and inpatient volume declines.
More articles on healthcare finance:
Baldwin Area Medical Center secures $28.5M for replacement facility
For-profit hospital stock report: Week of Nov. 3-7
HHS significantly lowers estimation for 2015 open enrollment sign-ups
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
